Autoimmune diseases develop when your immune system mistakenly attacks your own tissues, and no single cause is responsible. Instead, a combination of genetic susceptibility, environmental exposures, hormonal factors, and disruptions to the gut barrier converge to break the body’s tolerance of its own cells. These conditions affect roughly 8% to 10% of the world’s population, and the global prevalence nearly doubled between 1990 and 2021.
What makes autoimmune disease so difficult to pin down is its long fuse. In lupus, for example, autoantibodies (immune proteins that target the body’s own tissues) can appear in the blood up to 9 years before a person develops any symptoms. In rheumatoid arthritis, similar markers have been detected 8 years before diagnosis. The disease process is already underway long before you feel anything, which means the causes are often stacking up quietly over years.
Genetic Susceptibility Sets the Stage
Your genes don’t cause autoimmune disease on their own, but they heavily influence your risk. The most important genetic region is a cluster of genes involved in helping your immune system distinguish “self” from “foreign.” These genes, part of the human leukocyte antigen (HLA) system, code for proteins that sit on the surface of your cells and present fragments of proteins to immune cells for inspection. Variations in these genes can make that identification process error-prone.
Different autoimmune diseases are linked to different genetic variants, and risk varies across ethnic groups. Rheumatoid arthritis, for instance, is associated with one set of HLA variants in people of European descent and different variants in Japanese, Spanish, Greek, and Native American populations. Lupus is associated with variants that roughly double a person’s risk. Type 1 diabetes has its own set of high-risk variants, some of which were among the first to be identified decades ago.
Having these genetic variants doesn’t guarantee you’ll develop an autoimmune condition. Most people who carry high-risk genes never do. But these variants lower the threshold, making it easier for environmental triggers to tip the immune system toward self-attack.
Why Women Are Far More Affected
Women account for roughly 80% of autoimmune disease cases, and for a long time the explanation was vaguely attributed to “hormones.” A 2024 study from Stanford Medicine identified a far more specific mechanism rooted in the X chromosome itself.
Every cell in a woman’s body carries two X chromosomes, but only one needs to be active. Early in embryonic development, each cell shuts down one of its two X chromosomes using a long molecule called Xist. Xist physically coats the extra X chromosome, silencing its genes so the cell doesn’t produce double the normal amount of X-linked proteins. Males have only one X chromosome and don’t produce Xist.
The problem is that Xist doesn’t work alone. It recruits close to 100 different proteins to help it latch onto and silence the chromosome, and the resulting molecular complexes are unlike anything else in the body. The Stanford team found that these unfamiliar structures can trigger antibodies, essentially training the immune system to react to molecular patterns that exist only in female cells. Many of the proteins Xist recruits had already been independently linked to autoimmune disorders, which finally offered a concrete biological explanation for the striking sex gap.
Infections and Molecular Mimicry
One of the most well-established triggers for autoimmune disease is infection, particularly when a pathogen’s proteins closely resemble your own. This resemblance, called molecular mimicry, tricks the immune system into attacking both the invader and the body’s own tissues.
Epstein-Barr virus (EBV), which infects roughly 95% of adults worldwide, is the most studied example. EBV gains entry to immune cells by producing a surface protein that mimics the shape and electrical charge of a natural human protein. The viral protein fits the same molecular “lock” on the cell surface that the body’s own protein uses, essentially impersonating it. When the immune system mounts a response to this viral protein, it can also generate antibodies that cross-react with normal tissues.
Molecular mimicry isn’t limited to viruses. Certain gut bacteria produce proteins that resemble human proteins closely enough to confuse the immune system. One common oral bacterium produces a version of a human enzyme that triggers cross-reactive antibodies linked to rheumatoid arthritis. Another gut bacterium produces a protein similar to a component of human nerve insulation, potentially contributing to conditions that attack the nervous system. A third has been linked to antiphospholipid syndrome through a similar mechanism.
The Gut Barrier and Immune Tolerance
Your intestinal lining is a single layer of cells held together by protein structures called tight junctions. When these junctions weaken, the gut becomes more permeable, allowing bacteria, bacterial fragments, and undigested food proteins to cross into the bloodstream. This state of increased permeability, sometimes called “leaky gut,” sets off inflammatory responses both locally and throughout the body.
One key player in this process is a protein called zonulin, which regulates tight junctions. When zonulin signaling goes haywire, it triggers a chain reaction that pulls tight junctions apart, increasing permeability. Once the barrier is compromised, bacteria that normally live harmlessly in the gut can translocate to the liver and other organs, where they ramp up inflammation and stimulate the production of autoantibodies.
Specific bacterial species have been implicated. One, called Enterococcus gallinarum, has been shown to cross a damaged gut barrier, reach the liver, and directly increase autoantibody production by boosting the expression of proteins the immune system then targets. Another, Porphyromonas gingivalis (a bacterium also linked to gum disease), alters the overall composition of gut bacteria and suppresses tight junction proteins, making the barrier even leakier. The result is a self-reinforcing cycle: barrier damage allows bacterial escape, which drives inflammation, which damages the barrier further.
Chemical and Dietary Exposures
Certain environmental chemicals are strongly linked to autoimmune disease, particularly with prolonged exposure. Trichloroethylene (TCE), an industrial solvent found at contaminated sites and sometimes in drinking water, is one of the most studied. In animal models, exposure to TCE at very low doses accelerated lupus-like autoimmune responses within just 4 weeks, producing elevated autoantibodies and inflammatory immune signaling. After 32 to 48 weeks of exposure, animals developed autoimmune hepatitis, inflammatory skin lesions, and hair loss. In humans, occupational TCE exposure has been linked to scleroderma, with men in exposed occupations showing 2.5 times the odds of developing the condition compared to unexposed workers.
Crystalline silica, encountered in mining, construction, and sandblasting, is another established trigger. Cigarette smoking and ultraviolet radiation exposure have also been shown to promote autoimmune disease through measurable changes in how genes are regulated.
Diet plays a role too, particularly the modern processed food supply. Ultra-processed foods contain additives like emulsifiers, artificial sweeteners, preservatives, and colorants that can damage multiple layers of the intestinal barrier. These additives disrupt the gut’s microbial balance, thin the protective mucus layer, weaken the epithelial lining, and alter the behavior of immune cells stationed just beneath it. When the barrier breaks down, the immune system encounters a flood of bacterial material it normally never sees, and the result is an overblown immune response that can become self-directed.
Reduced Microbial Exposure in Early Life
The rise of autoimmune diseases in industrialized countries has tracked closely with increasingly sanitized living conditions, reduced contact with animals and soil, and widespread antibiotic use. The “Old Friends” hypothesis explains this by pointing out that the human immune system evolved alongside certain microorganisms, many of them symbiotic, that are essential for training immune cells to tolerate harmless substances, including the body’s own tissues.
These organisms, acquired from mothers during birth and breastfeeding, from family members, and from the natural environment, drive the expansion of regulatory T cells. These are the immune cells responsible for keeping inflammatory responses in check and preventing the immune system from attacking self. When children grow up with less exposure to these microbial “old friends,” their regulatory immune networks may develop incompletely, leaving them more prone to inflammatory and autoimmune conditions later in life.
Antibiotic use in early life, and even antibiotic exposure in utero, has been correlated with later metabolic and immunoregulatory problems, likely because antibiotics disrupt the microbial communities that would otherwise be shaping the developing immune system during a critical window.
Epigenetics: Where Environment Meets Genes
Epigenetics is the bridge between your fixed genetic code and the environmental exposures you accumulate over a lifetime. Epigenetic changes don’t alter your DNA sequence, but they control which genes are turned on or off by adding or removing chemical tags on the DNA itself or on the proteins that package it. These changes can be triggered by infections, UV exposure, smoking, diet, medications, hormones, and chemical exposures like silica dust.
In autoimmune disease, epigenetic shifts in immune cells can reactivate genes that should stay silent, or silence genes that normally keep the immune system in check. The result is a breakdown of self-tolerance: immune cells begin recognizing the body’s own proteins as threats. Because epigenetic marks can persist for years and even be passed to daughter cells, a single triggering event can have lasting consequences for immune function. This helps explain why autoimmune diseases often emerge years after the initial exposure, and why the same environmental factor can cause disease in one genetically susceptible person but not in another.